


FDA Approves Golimumab for Patients with pJIA & Psoriatic Arthritis

Guselkumab Approved for PsA

FDA Approves Secukinumab for Non-Radiographic Axial Spondyloarthritis
FDA Approves Tremfya (Guselkumab) for Adult Patients with Psoriatic Arthritis

FDA Approves the Biosimilar Hadlima (Adalimumab-bwwd)
